These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2611918)

  • 41. Dermal mucinosis in the eosinophilia-myalgia syndrome.
    Farmer KL; Hebert AA; Rapini RP; Jordan RE
    Arch Dermatol; 1990 Nov; 126(11):1518-20. PubMed ID: 2241211
    [No Abstract]   [Full Text] [Related]  

  • 42. Eosinophilia myalgia syndrome: case report.
    Abels LF; Slama TG
    Indiana Med; 1990 Apr; 83(4):270-1. PubMed ID: 2332620
    [No Abstract]   [Full Text] [Related]  

  • 43. Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome.
    Mayeno AN; Lin F; Foote CS; Loegering DA; Ames MM; Hedberg CW; Gleich GJ
    Science; 1990 Dec; 250(4988):1707-8. PubMed ID: 2270484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eosinophilia-myalgia syndrome: a clinicopathological study of four patients.
    Villanova M; De Clerck LS; Cras P; Ceuterick C; Van Marck E; Guazzi GC; Martin JJ
    Clin Neuropathol; 1993; 12(4):201-3. PubMed ID: 8403629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Axonal neuropathy in eosinophilia-myalgia syndrome.
    Burns SM; Lange DJ; Jaffe I; Hays AP
    Muscle Nerve; 1994 Mar; 17(3):293-8. PubMed ID: 8107705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [L-tryptophan and the eosinophilia-myalgia syndrome].
    Prick JJ
    Ned Tijdschr Geneeskd; 1990 Aug; 134(31):1516-7. PubMed ID: 2392173
    [No Abstract]   [Full Text] [Related]  

  • 47. Tryptophan.
    JAMA; 1990 Aug 22-29; 264(8):969-71. PubMed ID: 2376885
    [No Abstract]   [Full Text] [Related]  

  • 48. [Eosinophilic fasciitis: its relationship with L-tryptophan ingestion].
    Lucena Marotta F; Sanz Moreno J; Herrera Serrano L; López Alvarez J; Alvarez de Buergo Ballester M
    An Med Interna; 1995 Jul; 12(7):337-9. PubMed ID: 7578816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
    Shapiro S
    J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From the National Institutes of Health.
    Raub W
    JAMA; 1991 Jan; 265(1):19. PubMed ID: 1984118
    [No Abstract]   [Full Text] [Related]  

  • 51. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
    Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic bias in clinical decision making: an example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome.
    Wagner KR; Elmore JG; Horwitz RI
    J Rheumatol; 1996 Dec; 23(12):2079-85. PubMed ID: 8970044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
    Sullivan EA; Staehling N; Philen RM
    J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration].
    Schnabel A; Reusch M; Christophers E; Gross WL
    Internist (Berl); 1994 Jan; 35(1):63-6. PubMed ID: 8144322
    [No Abstract]   [Full Text] [Related]  

  • 55. [Demyelinating nervous lesions in myalgia-eosinophilia syndrome induced by L Tryptophan].
    Labauge P; Moulonguet A; Penaud D; Lessana-Leibowitch M; Kahn MF; Said G
    Rev Neurol (Paris); 1993; 149(4):278-82. PubMed ID: 8235226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced severity of eosinophilia-myalgia syndrome associated with the consumption of vitamin-containing supplements before illness.
    Hatch DL; Goldman LR
    Arch Intern Med; 1993 Oct; 153(20):2368-73. PubMed ID: 8215741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia myalgia syndrome.
    Suzuki S; Tourkina E; Ludwicka A; Hampton M; Bolster M; Maize J; Silver R
    Proc Assoc Am Physicians; 1996 Jul; 108(4):315-22. PubMed ID: 8863345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
    Sidransky H
    Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia.
    Margolin L
    J Rheumatol; 2003 Mar; 30(3):628-9. PubMed ID: 12610828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.